NASDAQ:NVIV
InVivo Therapeutics Holdings Corp. Stock Company Profile
$0.321
+0 (+0%)
At Close: Apr 18, 2024
Information
One Kendall Square, 4th Floor Suite B14402 Building 1400 West
Cambridge MA 02139
617 863 5500
www.invivotherapeutics.com
Industry: Biotechnology
Sector: Healthcare
Description
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.
